Coverart for item
The Resource Reputation and power : organizational image and pharmaceutical regulation at the FDA, Daniel Carpenter

Reputation and power : organizational image and pharmaceutical regulation at the FDA, Daniel Carpenter

Label
Reputation and power : organizational image and pharmaceutical regulation at the FDA
Title
Reputation and power
Title remainder
organizational image and pharmaceutical regulation at the FDA
Statement of responsibility
Daniel Carpenter
Creator
Author
Subject
Language
eng
Summary
The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industr
Member of
Cataloging source
N$T
Illustrations
  • illustrations
  • maps
Index
index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
Series statement
Princeton studies in American politics : historical, international, and comparative perspectives
Reputation and power : organizational image and pharmaceutical regulation at the FDA, Daniel Carpenter
Label
Reputation and power : organizational image and pharmaceutical regulation at the FDA, Daniel Carpenter
Link
http://www.jstor.org/stable/10.2307/j.ctt7t5st
Publication
Related Contributor
Related Location
Related Agents
Related Authorities
Related Subjects
Related Items
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Reputation and the organizational politics of new drug review
  • The governance of research and development : gatekeeping power, conceptual guidance, and regulation by satellite
  • The other side of the gate : reputation, power, and post-market regulation
  • The détenté of firm and regulator
  • American pharmaceutical regulations in international context : audiences, comparisons, and dependencies
  • Conclusion:
  • A reputation in brief
  • Introduction:
  • The gatekeeper
  • Reputation and regulatory power
  • Reputation and gatekeeping authority : the federal Food, Drug, and Cosmetic Act of 1938 and its aftermath
  • The ambiguous emergence of American pharmaceutical regulation, 1944-1961
  • Reputation and power crystallized : thalidomide, Frances Kelsey, and phased experiment, 1961-1966
  • Reputation and power institutionalized : scientific networks, congressional hearings, and judicial affirmations, 1963-1986
  • Reputation and power contested : emboldened audiences in cancer and AIDS, 1977-1992
http://library.link/vocab/cover_art
https://contentcafe2.btol.com/ContentCafe/Jacket.aspx?Return=1&Type=S&Value=9781400835119&userID=ebsco-test&password=ebsco-test
Dimensions
unknown
http://library.link/vocab/discovery_link
{'f': 'http://opac.lib.rpi.edu/record=b4325119'}
Extent
1 online resource (xx, 802 pages)
File format
unknown
Form of item
online
Isbn
9781400835119
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations, map.
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote

Library Locations

    • Folsom LibraryBorrow it
      110 8th St, Troy, NY, 12180, US
      42.729766 -73.682577
Processing Feedback ...